Genpact SVP reports share sale and tax withholding

Genpact Limited senior vice president Riju Vashisht reported two transactions in the company’s common shares.

Rhea-AI Filing Summary

Genpact Limited senior vice president Riju Vashisht reported two transactions in the company’s common shares. On January 10, 2026, 10,733 shares were withheld to cover taxes upon vesting of restricted share units under the Genpact Limited 2017 Omnibus Incentive Compensation Plan at a price of $48.24 per share. This was a tax-related withholding rather than an open-market sale.

On January 13, 2026, Vashisht sold 16,016 common shares at a weighted average price of $46.65 per share, with actual prices ranging from $46.40 to $47.05. These sales were executed under a pre-established Rule 10b5-1 trading plan adopted on September 11, 2025. After these transactions, Vashisht directly held 95,521 Genpact common shares.

Insider Trade Summary

Net Seller: 16,016 shares

Net Sell 2 txns

Insider Vashisht Riju

Role Senior Vice President

Sold 16,016 shs ($747K)

Type	Security	Shares	Price	Value
Sale	Common Shares	16,016	$46.65	$747K
Exercise Price or Tax Liability	Common Shares	10,733	$48.24	$518K

Holdings After Transaction: Common Shares — 95,521 shares (Direct)

Footnotes (3)

1. F1. Represents shares withheld for payment of taxes upon the vesting of restricted share units granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan and exempt under Rule 16b-3.
2. F2. The sales transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 11, 2025.
3. F3. The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $46.40 to $47.05. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider activity did Genpact (G) report for Riju Vashisht?

The filing shows that Senior Vice President Riju Vashisht had 10,733 Genpact common shares withheld for taxes on January 10, 2026, and sold 16,016 common shares on January 13, 2026, with 95,521 shares directly owned afterward.

How many Genpact (G) shares did Riju Vashisht sell and at what price?

On January 13, 2026, Riju Vashisht sold 16,016 Genpact common shares at a weighted average price of $46.65 per share, with individual sale prices ranging from $46.40 to $47.05.

Were the Genpact (G) insider sales by Riju Vashisht under a Rule 10b5-1 plan?

Yes. The filing states that the sales transactions reported were effected pursuant to a Rule 10b5-1 trading plan adopted by Riju Vashisht on September 11, 2025.

Why were 10,733 Genpact (G) shares withheld in Riju Vashisht’s Form 4?

The 10,733 shares were withheld to pay taxes upon the vesting of restricted share units granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan, and are noted as exempt under Rule 16b-3.

How many Genpact (G) shares does Riju Vashisht own after the reported transactions?

Following the tax withholding and the sale reported, Riju Vashisht directly owns 95,521 Genpact common shares according to the Form 4.

What is Riju Vashisht’s role at Genpact (G) in this insider filing?

Riju Vashisht is identified as an officer of Genpact Limited, serving as Senior Vice President, and is not listed as a director or 10% owner in the filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/13/2026 - 09:32 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Vashisht Riju

(Last) (First) (Middle)

C/O GENPACT LLC

521 FIFTH AVENUE, 14TH FLOOR

(Street)

NEW YORK NY 10175

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Genpact LTD [ G ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Senior Vice President

3. Date of Earliest Transaction (Month/Day/Year)
01/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	01/10/2026		F		10,733(1)	D	$48.24	111,537	D
Common Shares	01/13/2026		S		16,016(2)	D	$46.65(3)	95,521	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares withheld for payment of taxes upon the vesting of restricted share units granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan and exempt under Rule 16b-3.

2. The sales transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 11, 2025.

3. The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $46.40 to $47.05. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Remarks:

	/s/ Thomas D. Scholtes, as Attorney-in-fact for Riju Vashisht	01/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.